Extendicare Inc.
EXETF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 12.4% | 6.8% | 4.7% | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 100% | 12.8% | 6.3% | 9.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 10.6% | 7.6% | 4% | 6.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 5.1% | 2.6% | 5.7% | 1% |
| EPS Diluted | 0.86 | 0.4 | -0.053 | 0.11 |
| % Growth | 115% | 860.5% | -147.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |